Press Releases

Landmark celebration of the Indian Pharma Industry as the 10th edition of CPhI & P-MEC India gets underway

The Indian pharmaceutical industry saw the launch of the grand 10th anniversary edition of UBM India’s signature event, CPhI & P-MEC India 2016, one of the world’s leading pharma networking expos.  To celebrate the landmark, this...

New Multi-Scale Imaging System Provides Insight into a Material’s Internal 3D Structure

Materials scientists can now gain valuable insight into the relationships between a material’s structure at the microscopic level and its bulk properties using a new multi-scale imaging solution that is designed to provide large-scale, high-fidelity three-dimensional (3D) images of...

Novo Nordisk receives US FDA approval for Xultophy 100/3.6

Novo Nordisk announced that the US FDA has approved the NDA for Xultophy® 100/3.6.Xultophy® 100/3.6 is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin...

GSK receives FDA approval for expanded indication for FluLaval Quadrivalent for infants 6 months and older

GSK  announced it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication for FluLaval® Quadrivalent (Influenza Vaccine) to include use in children 6 months and older. ...

UBM India’s India Pharma Week 2016 debuts to commemorate a decade of the world’s leading pharma event, CPhI & P-MEC

UBM India, India's leading exhibition organizer, launched the India Pharma Week, a bouquet of over 10 trend-setting activities across the city of Mumbai, to mark the special 10th anniversary of CPhI & P-MEC India 2016, its flagship event and...

Egalet Announces OXAYDO® Receives Pharmaceutical Composition Patent Protection Through 2024

Egalet Corporation , a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,announced the issuance of a United States patent covering OXAYDO® (oxycodone HCI, USP) tablets for oral use only–CII....

Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System – the First Commercially Available Patient-matched Glenoid Implant 

Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare,announced the launch of the Comprehensive® Vault Reconstruction System (VRS),the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read